Drug Trial Radar · NCT07133633
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
315
Planned (sponsor's estimate)
Start
Sep 26, 2025
Primary completion
Mar 29, 2027
Study completion Feb 5, 2030
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Aug 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers are looking for new ways to treat radiographic axial spondyloarthritis (r-axSpA). R-axSpA is a type of arthritis that causes pain, stiffness, and inflammation (swelling) in the spine and joints in the pelvis (hip bone). Radiographic means the damage it causes can be seen on X-rays. This study will help find out if a study medicine called tulisokibart can treat symptoms of r-axSpA. Researchers will look at different doses of tulisokibart. Researchers want to know if at least one of the study doses of tulisokibart works better than a placebo to improve r-axSpA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.
Conditions
- Radiographic Axial Spondyloarthritis
Interventions
TulisokibartDrug
Subcutaneous (SC) administration
PlaceboDrug
SC administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Assessment of Spondyloarthritis International Society (ASAS) 40 Response at Week 16Time frame: Week 16
Locations
108 sites in 14 countries. Site status is shown where the registry gives one.
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Chandler ( Site 0036)
Chandler, Arizona
AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff ( Site 0021)
Flagstaff, Arizona
Arizona Arthritis & Rheumatology Associates, P.C. - Gilbert ( Site 0022)
Gilbert, Arizona
AARA Arizona Arthritis & Rheumatology Associates, P.C. - Glendale ( Site 0056)
Glendale, Arizona
Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 0025)
Tucson, Arizona
TriWest Research Associates - Chula Vista ( Site 0013)
Chula Vista, California
Providence Medical Foundation ( Site 0049)
Fullerton, California
Newport Huntington Medical Group ( Site 0005)
Huntington Beach, California
Cohen Medical Centers ( Site 0034)
Thousand Oaks, California
Inland Rheumatology Clinical Trials, Inc. ( Site 0002)
Upland, California
Denver Arthritis Clinic ( Site 0064)
Denver, Colorado
Arthritis and Rheumatic Disease Specialties ( Site 0016)
Aventura, Florida
Bay Area Arthritis and Osteoporosis ( Site 0041)
Brandon, Florida
GNP Research - Hollywood ( Site 0020)
Cooper City, Florida
Innovation Medical Research Center ( Site 0012)
Palmetto Bay, Florida
Chicago Arthritis & Regenerative Medicine ( Site 0042)
Chicago, Illinois
Willow Rheumatology and Wellness, PLLC ( Site 0035)
Willowbrook, Illinois
John Hopkins University ( Site 0052)
Baltimore, Maryland
Arthritis and Rheumatism Associates - Rockville ( Site 0019)
Rockville, Maryland
Kansas City Physician Partners ( Site 0027)
Kansas City, Missouri
Velocity Clinical Research - West County Rheumatology, St. Louis ( Site 0038)
St Louis, Missouri
Logan Health Rheumatology ( Site 0015)
Kalispell, Montana
Physician Research Collaboration, LLC ( Site 0057)
Lincoln, Nebraska
Inspire Santa Fe Medical Group ( Site 0011)
Santa Fe, New Mexico
Joseph S. and Diane H. Steinberg Ambulatory Care Center ( Site 0063)
Brooklyn, New York
Oregon Health & Science University ( Site 0059)
Portland, Oregon
Altoona Center for Clinical Research ( Site 0004)
Duncansville, Pennsylvania
Perelman Center for Advanced Medicine ( Site 0060)
Philadelphia, Pennsylvania
AARA Clinical Research - Murfreesboro Medical Clinic ( Site 0029)
Murfreesboro, Tennessee
Rheumatology Associates ( Site 0055)
Arlington, Texas
Arthritis Care of Texas ( Site 0048)
Corpus Christi, Texas
Lone Star Arthritis & Rheumatology Associates, P.C. ( Site 0028)
Fort Worth, Texas
Provecta Research Network LLC ( Site 0054)
Houston, Texas
The University of Texas Health Science Center at Houston ( Site 0065)
Houston, Texas
AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving ( Site 0032)
Irving, Texas
Epic Medical Research ( Site 0061)
Red Oak, Texas
Advanced Rheumatology of Houston ( Site 0001)
The Woodlands, Texas
DM Clinical Research - TRA ( Site 0010)
Tomball, Texas
IBPClin - Instituto Brasil de Pesquisa Clínica ( Site 1994)
Rio de Janeiro, Brazil
Centro de Pesquisas Clínicas do Hospital das Clínicas de São Paulo ( Site 1992)
São Paulo, Brazil
Showing 40 of 108 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.